To determine whether autologous hematopoietic stem cell transplantation (aHSCT) is able to induce durable disease remission in people with multiple sclerosis (MS), we analyzed the long-term outcomes after transplant in a large cohort of MS patients.
Long-Term Clinical Outcomes of Hematopoietic Stem Cell Transplantation in Multiple Sclerosis
Capobianco, Marco;De Gobbi, Marco;Bertolotto, Antonio;Uccelli, Antonio;
2021-01-01
Abstract
To determine whether autologous hematopoietic stem cell transplantation (aHSCT) is able to induce durable disease remission in people with multiple sclerosis (MS), we analyzed the long-term outcomes after transplant in a large cohort of MS patients.
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
NEUROLOGY-2020-096313v3-Inglese.pdf
Open Access dal 22/01/2022
Tipo di file:
POSTPRINT (VERSIONE FINALE DELL’AUTORE)
Dimensione
303.24 kB
Formato
Adobe PDF
|
303.24 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
